Literature DB >> 19682551

Ion beam radiobiology and cancer: time to update ourselves.

Emmanouil Fokas1, Gerhard Kraft, Hanxiang An, Rita Engenhart-Cabillic.   

Abstract

High-energy protons and carbon ions exhibit an inverse dose profile allowing for increased energy deposition with penetration depth. Additionally, heavier ions like carbon beams have the advantage of a markedly increased biological effectiveness characterized by enhanced ionization density in the individual tracks of the heavy particles, where DNA damage becomes clustered and therefore more difficult to repair, but is restricted to the end of their range. These superior biophysical and biological profiles of particle beams over conventional radiotherapy permit more precise dose localization and make them highly attractive for treating anatomically complex and radioresistant malignant tumors but without increasing the severe side effects in the normal tissue. More than half a century since Wilson proposed their use in cancer therapy, the effects of particle beams have been extensively investigated and the biological complexity of particle beam irradiation begins to unfold itself. The goal of this review is to provide an as comprehensive and up-to-date summary as possible of the different radiobiological aspects of particle beams for effective application in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682551     DOI: 10.1016/j.bbcan.2009.07.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  41 in total

Review 1.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

2.  Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions.

Authors:  Otilija D Keta; Danijela V Todorović; Tanja M Bulat; Pablo Ga Cirrone; Francesco Romano; Giacomo Cuttone; Ivan M Petrović; Aleksandra M Ristić Fira
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-15

3.  Chromosome aberration measurements in mitotic and G2-PCC lymphocytes at the standard sampling time of 48 h underestimate the effectiveness of high-LET particles.

Authors:  Ryonfa Lee; Elena Nasonova; Carola Hartel; Marco Durante; Sylvia Ritter
Journal:  Radiat Environ Biophys       Date:  2011-04-11       Impact factor: 1.925

Review 4.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

Review 5.  Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.

Authors:  Christopher Allen; Thomas B Borak; Hirohiko Tsujii; Jac A Nickoloff
Journal:  Mutat Res       Date:  2011-03-03       Impact factor: 2.433

Review 6.  Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma.

Authors:  Yasuteru Kondo; Osamu Kimura; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

7.  Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer.

Authors:  Yusuke Azami; Yuichiro Hayashi; Tatsuya Nakamura; Kanako Kimura; Hisashi Yamaguchi; Takashi Ono; Kanako Takayama; Katsumi Hirose; Tomonori Yabuuchi; Motohisa Suzuki; Yoshiomi Hatayama; Masato Hareyama; Yasuhiro Kikuchi; Nobukazu Fuwa
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-07-09

8.  Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.

Authors:  Kanako Takayama; Tatsuya Nakamura; Akinori Takada; Chiyoko Makita; Motohisa Suzuki; Yusuke Azami; Takahiro Kato; Yuichiro Hayashi; Takashi Ono; Yutaka Toyomasu; Masato Hareyama; Yasuhiro Kikuchi; Takashi Daimon; Kenji Mitsudo; Iwai Tohnai; Nobukazu Fuwa
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-31       Impact factor: 4.553

9.  Establishment of a mammalian cell line suitable for industrial production of recombinant protein using mutations induced by high-energy beam radiation.

Authors:  Yasuhito Chida; Keiichi Takagi; Satoshi Terada
Journal:  Cytotechnology       Date:  2013-05-10       Impact factor: 2.058

Review 10.  Particle therapy for cancers: a new weapon in radiation therapy.

Authors:  Guo-Liang Jiang
Journal:  Front Med       Date:  2012-05-09       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.